| abstract |
Thrombus characterized by using blood collected with a sodium citrate-containing blood collection tube and adding blood, blood coagulation factor XII (FXII) inhibitor and kallikrein inhibitor to the blood to initiate blood coagulation reaction Methods for analyzing the ability to form or coagulate blood are provided. Preferably, heparin, heparan sulfate, and tissue factor are further added to the blood, and analysis of thrombus formation ability or blood coagulation ability is performed. |